These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacodynamics of high-dose chemotherapy. Nieto Y Curr Drug Metab; 2001 Mar; 2(1):53-66. PubMed ID: 11465151 [TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted Therapies. Calvo E; Walko C; Dees EC; Valenzuela B Am Soc Clin Oncol Educ Book; 2016; 35():e175-84. PubMed ID: 27249721 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic-pharmacokinetic relationships and therapeutic drug monitoring. Kobayashi K; Jodrell DI; Ratain MJ Cancer Surv; 1993; 17():51-78. PubMed ID: 8137353 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics and pharmacodynamics of anticancer agents in pediatric patients (review). Knoester PD; Underberg WJ; Beijnen JH Anticancer Res; 1993; 13(5C):1795-808. PubMed ID: 8267385 [TBL] [Abstract][Full Text] [Related]
10. Using pharmacogene polymorphism panels to detect germline pharmacodynamic markers in oncology. Hertz DL; McLeod HL Clin Cancer Res; 2014 May; 20(10):2530-40. PubMed ID: 24831276 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in children. Rodman JH; Relling MV; Stewart CF; Synold TW; McLeod H; Kearns C; Stute N; Crom WR; Evans WE Semin Oncol; 1993 Feb; 20(1):18-29. PubMed ID: 8475406 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacodynamics of anticancer agents]. Ohtsu T; Sasaki Y Gan To Kagaku Ryoho; 1993 Sep; 20(12):1741-9. PubMed ID: 8379667 [TBL] [Abstract][Full Text] [Related]
13. Adaptive control methods for the dose individualisation of anticancer agents. Rousseau A; Marquet P; Debord J; Sabot C; Lachâtre G Clin Pharmacokinet; 2000 Apr; 38(4):315-53. PubMed ID: 10803455 [TBL] [Abstract][Full Text] [Related]
14. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment. Mathijssen RH; van Schaik RH Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399 [TBL] [Abstract][Full Text] [Related]
15. [Usefulness of a pharmacokinetic approach for clinical antineoplastic chemotherapy evaluation]. Lokiec F Bull Cancer; 1999 Apr; 86(4):341-4. PubMed ID: 10341339 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring in cancer management. Galpin AJ; Evans WE Clin Chem; 1993 Nov; 39(11 Pt 2):2419-30. PubMed ID: 8222253 [TBL] [Abstract][Full Text] [Related]
17. Cancer pharmacogenomics: achievements in basic research. Nakajima M; Yokoi T Int J Clin Oncol; 2005 Feb; 10(1):14-9. PubMed ID: 15729595 [TBL] [Abstract][Full Text] [Related]
18. Platinum complexes in cancer medicine: pharmacokinetics and pharmacodynamics in relation to toxicity and therapeutic activity. Calvert H; Judson I; van der Vijgh WJ Cancer Surv; 1993; 17():189-217. PubMed ID: 8137341 [TBL] [Abstract][Full Text] [Related]
19. [Clinical pharmacology in development of new anticancer agents]. Sasaki Y Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():310-4. PubMed ID: 7986109 [TBL] [Abstract][Full Text] [Related]